MedPath

The Outcomes of Laparoscopic Hybrid Surgery Versus Totally Open Surgery

Completed
Conditions
Resectable Simultaneous Colorectal Cancer Liver Metastasis
Interventions
Procedure: laparoscopic hybrid surgery (LHS)
Registration Number
NCT06550700
Lead Sponsor
Changhai Hospital
Brief Summary

Simultaneous colorectal cancer liver metastasis (SCRLM) is one of the risk factors for poor prognosis in colorectal cancer. Surgical resection of primary and metastatic lesions is the first choice of treatment for patients with resectable SCRLM. Simultaneous resection of colorectal cancer liver metastases by totally open surgery (TOS) has been widely used. However, we propose that laparoscopic hybrid surgery (LHS) may have better short and long-term outcomes. This study aimed to compare the safety, short-term, and long-term efficacy of LHS versus TOS for patients with resectable SCRLMs.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
266
Inclusion Criteria
  • Liver metastasis was detected while the colorectal cancer was diagnosed.
  • Both the primary lesions and liver metastases were confirmed by postoperative pathological examination.
  • Clinical data is complete.
Exclusion Criteria
  • Patients with unresectable extrahepatic metastases.
  • Patients with other malignant tumor diseases that have not been cured.
  • Clinical and pathological data were missed or incomplete follow-up data.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
laparoscopic hybrid surgery (LHS) cohortlaparoscopic hybrid surgery (LHS)Routine colorectal surgery is performed first, followed by liver surgery. The LHS cohort first performed the laparoscopic exploration of the entire abdominal-pelvic cavity to determine the resectability of the primary and metastatic lesions. After the blood vessel detachment and bowel detachment, the distal bowel of the tumor was severed and the pneumoperitoneum was closed. The liver metastases were then removed in both cohorts by open resection through the right subcostal incision.
Primary Outcome Measures
NameTimeMethod
short-term outcome: Operative timeWithin one week of the patient undergoing surgery

Time taken for surgery

short-term outcome: Postoperative hospital stayWithin one week of the patient undergoing surgery

Length of stay of patients after surgery

short-term outcome: Surgical complicationsWithin one week of the patient undergoing surgery

Complications that occur in patients after surgery

short-term outcome: Blood lossWithin one week of the patient undergoing surgery

Patient haemorrhage during surgery

short-term outcome: Time of liquid dietWithin one week of the patient undergoing surgery

Time for patients to eat fluids for the first time after surgery

Secondary Outcome Measures
NameTimeMethod
disease-free survival (DFS)3years

the time after surgical treatment until the first observation of tumor recurrence or death for any reason

overall survival (OS)3years

the time after surgical treatment until death for any reason

Trial Locations

Locations (1)

Department of Colorectal Surgery in Changhai Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath